MDR and drugs for pediatrics: how to navigate within the regulatory ocean?
What is the regulatory roadmap for paediatric medical devices and drugs before they can be marketed?
i4KIDS I i4KIDS-EUROPE Training Capsule dedicated to learn how to drive innovation through regulatory roadmaps for both Medical Devices Regulation (MDR) and Drugs Regulation with Xavier Luria, a seasoned expert in Medical Devices and Drugs regulation with extensive experience at European Medicines Agency, illuminates strategies to reflect on the regulatory landscape in Europe.
SESSION IN ENGLISH
Related News
Featured
i4KIDS and Impact1 at the Stanford Mussallem Center for Biodesign are launching a new edition of Impact4Kids, the transatlantic acceleration programme designed for start-ups, companies and research teams developing innovative solutions in fetal, paediatric and maternal health.
Featured
i4KIDS has completed its first season of collaboration with RNE's Cuídate programme, featuring nine episodes focused on paediatric and foetal health innovation. The series brought together healthcare professionals, researchers and innovators to discuss advances in areas such as rare diseases, paediatric haematology, prematurity, neurodevelopment, congenital heart disease and paediatric palliative care.
Featured
Applications Now Open for CRAASH Barcelona and DKV Challenge 2026 with i4KIDS as a Strategic Partner
i4KIDS is reinforcing its commitment to innovation in paediatric, fetal and maternal health by collaborating in two strategic initiatives currently open for applications: CRAASH Barcelona 2026 and DKV Challenge 2026. Both programmes offer new opportunities for startups and innovative projects seeking to accelerate the development, validation and adoption of solutions with an impact on maternal and child health.